Literature DB >> 16765604

TH1/TH2 cytokine balance in patients with both type 1 diabetes mellitus and asthma.

Marianna Rachmiel1, Olga Bloch, Tzvi Bistritzer, Naomi Weintrob, Regina Ofan, Nira Koren-Morag, Micha J Rapoport.   

Abstract

BACKGROUND AND
OBJECTIVE: T1DM and asthma are mediated by opposite arms of the cellular immune system namely T helper (Th)1 and Th2 CD4(+) cells, respectively. Our aim was to characterize the Th1/Th2 cytokine balance in patients with both T1DM and asthma.
METHODS: Forty-four patients, mean age 19 years were matched by gender and age, to 4 paired groups: T1DM and asthma, asthma only, T1DM only and healthy controls. Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with disease-specific recombinant antigens; glutamic acid decarboxylase and house dust mite (Der p1 antigen) for T1DM and asthma, respectively, and non-specific mitogens; phytohemaglutinin (PHA), tetanus toxin and anti-CD3 mAb. ELISPOT and ELISA technique were used to determine INF-gamma, IL-2, IL-4, IL-13 and IL-10 expression.
RESULTS: Patients with T1DM and asthma demonstrated a similar cytokine pattern but lower Th1/Th2 ratio compared to patients with T1DM only. The Th2 cytokines response to Der p1 was enhanced in patients with both diseases compared to controls. The IL-10 overall secretion was higher in patients with both diseases compared to one disease only.
CONCLUSION: The Th1 and Th2 secretory pattern of patients with T1DM and asthma combines features of both diseases suggesting a unique Th1/Th2 balance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765604     DOI: 10.1016/j.cyto.2006.04.012

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

Review 1.  Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer.

Authors:  Rajeswari Raguraman; Akhil Srivastava; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-08-08       Impact factor: 15.470

2.  Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.

Authors:  M N Pham; H Kolb; T Battelino; J Ludvigsson; P Pozzilli; F Zivehe; M Roden; T Mandrup-Poulsen; N C Schloot
Journal:  Diabetologia       Date:  2013-03-15       Impact factor: 10.122

3.  Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells.

Authors:  Gangduo Wang; Rolf König; G A S Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2008-01-26       Impact factor: 7.376

4.  The influence of exendin-4 intervention on -obese diabetic mouse blood and the pancreatic tissue immune microenvironment.

Authors:  Jinshui He; Chaowei Lian; Yanling Fang; Jinzhi Wu; Huowang Zhou; Xiaoling Ye
Journal:  Exp Ther Med       Date:  2016-09-12       Impact factor: 2.447

Review 5.  Diabetic lung disease: fact or fiction?

Authors:  Saeed Kolahian; Veronika Leiss; Bernd Nürnberg
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

6.  Continuous stimulation of dual-function peptide PGLP-1-VP inhibits the morbidity and mortality of NOD mice through anti-inflammation and immunoregulation.

Authors:  Huashan Gao; Qian Zhao; Shanshan Tang; Kaiying Li; Fujian Qin; Ziwei Song; Yi Pan; Liang Jin; Yanfeng Zhang
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

7.  Type 1 Diabetes and Increased Risk of Subsequent Asthma: A Nationwide Population-Based Cohort Study.

Authors:  Yung-Tsung Hsiao; Wen-Chien Cheng; Wei-Chih Liao; Cheng-Li Lin; Te-Chun Shen; Wei-Chun Chen; Chia-Hung Chen; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

8.  Applied immuno-epidemiological research: an approach for integrating existing knowledge into the statistical analysis of multiple immune markers.

Authors:  Bernd Genser; Joachim E Fischer; Camila A Figueiredo; Neuza Alcântara-Neves; Mauricio L Barreto; Philip J Cooper; Leila D Amorim; Marcus D Saemann; Thomas Weichhart; Laura C Rodrigues
Journal:  BMC Immunol       Date:  2016-05-20       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.